â– HISTOLOGY: The Pancreas is a dual-function gland.
- Exocrine portion (98% of tissue): Formed by tubuloacinar units secretes digestive enzymes.
- Endocrine portion (2% of tissue): Formed by the Islets of Langerhans, which are highly vascularized nests of endocrine cells scattered throughout the exocrine parenchyma.
â– PARACRINE ISLET ARCHITECTURE:
An islet contains up to 3,000 cells divided into three major functional types:
1. Beta (β) Cells (60-70% of islet, located CENTRALLY): Synthesize and secrete Insulin, which lowers blood glucose by promoting cellular intake.
2. Alpha (α) Cells (15-20% of islet, located PERIPHERALLY): Synthesize and secrete Glucagon, which raises blood glucose by promoting hepatic glycogenolysis.
3. Delta (δ) Cells (5-10% of islet, located scattered): Secrete Somatostatin, which acts as a local paracrine inhibitor of both insulin and glucagon.
â– IMMUNOLOGICAL & CYTOKINE SIGNALLING FLUX:
Pathogen exposure or cellular distress triggers antigen-presenting cell activation. This results in the release of pro-inflammatory cytokines (such as IL-1, TNF-alpha, and IL-6) and triggers receptor-mediated cellular chemotaxis.
â– SYSTEMIC HOMEOSTATIC REMODELING:
Prolonged pathologic strain causes adjacent cardiovascular, renal, or endocrine systems to remodel dynamically to maintain overall tissue perfusion.
[HY-BOARD-1296]
🌟 Dynamic Clinical Key:
In Type 1 Diabetes Mellitus, an autoimmune T-cell mediated attack selectively targets and destroys the central Beta cells of the Islets of Langerhans. This leads to a loss of insulin secretion, causing hyperglycemia, diabetic ketoacidosis, and requiring life-long insulin therapy. Target specific monoclonal antibodies or immune suppressors to control the hyper-inflammatory cascade. Intercept compensatory loops early before they turn into independent pathologic drivers.